Idaho Medicaid Drug Utilization Review Program . 18 April 2013. ADURS (American Drug Utilization Review Society). February 21-23, 2013 Scottsdale, Arizona Representatives present from 40 state Medicaid programs 109 total participants. ADURS.
Idaho Medicaid Drug Utilization Review Program
18 April 2013
ADURS (American Drug Utilization Review Society)
February 21-23, 2013
Representatives present from 40 state Medicaid programs
109 total participants
Narcotic Analgesic Update
Participants Receiving Over 500 mg Morphine Equivalents per Day
Lowest = 10 mg
Highest = 2421 mg
Payment Amount to Pharmacy: 12/12 - $25,787; 3/13 - $24,555
Same decision for all indications ?
Testosterone Injection DUR
Topical formulation of testosterone requires a prior authorization
Injectable testosterone does not require a prior authorization
Are testosterone injections being prescribed appropriately?
Are there duplicative treatments between outpatient pharmacy benefit and medical benefit (J-codes)?
Age: 0- 75 years Average of 41 years
Average days supply: 28 days ( range: 14-34 days
Average dispensed quantity: 4 mls (range: 1-10 mls)
The most prescribed: Testosterone cypionate 200mg vial
Prior Authorization of injectable testosterone for therapeutic diagnosis may be required to evaluate appropriate use and maintain consistency across the two programs
Foster Children Psychotropic Drugs Red Flags
Foster Children ADHD Drug Therapy Focus
*12 children’s therapy counted in 2-4 different entities included an IR/ER combination of one of the entities, not counted here
guanfacine ER (Intuniv) 15%
dexmethylphenidate IR 5 mg daily
dexmethylphenidate XR 15 mg daily
clonidine 0.2 mg daily
guanfacine 5 mg daily
atomoxetine 40 mg daily